Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Neurogastroenterol Motil. 2019 Jun;31 Suppl 2(Suppl 2):e13606. doi: 10.1111/nmo.13606.
Cannabis is commonly used in cyclic vomiting syndrome (CVS) due to its antiemetic and anxiolytic properties. Paradoxically, chronic cannabis use in the context of cyclic vomiting has led to the recognition of a putative new disorder called cannabinoid hyperemesis syndrome (CHS). Since its first description in 2004, numerous case series and case reports have emerged describing this phenomenon. Although not pathognomonic, a patient behavior called "compulsive hot water bathing" has been associated with CHS. There is considerable controversy about how CHS is defined. Most of the data remain heterogenous with limited follow-up, making it difficult to ascertain whether chronic cannabis use is causal, merely a clinical association with CVS, or unmasks or triggers symptoms in patients inherently predisposed to develop CVS. This article will discuss the role of cannabis in the regulation of nausea and vomiting, specifically focusing on both CVS and CHS, in order to address controversies in this context. To this objective, we have collated and analyzed published case series and case reports on CHS in order to determine the number of reported cases that meet current Rome IV criteria for CHS. We have also identified limitations in the existing diagnostic framework and propose revised criteria to diagnose CHS. Future research in this area should improve our understanding of the role of cannabis use in cyclic vomiting and help us better understand and manage this disorder.
大麻由于其止吐和抗焦虑特性,常用于周期性呕吐综合征(CVS)。具有讽刺意味的是,在周期性呕吐的情况下慢性大麻使用导致了一种被称为大麻素过度呕吐综合征(CHS)的假定新疾病的出现。自 2004 年首次描述以来,已经出现了许多描述这种现象的病例系列和病例报告。尽管不是特征性的,但有一种称为“强迫热水浴”的患者行为与 CHS 相关。关于如何定义 CHS 存在相当大的争议。大多数数据仍然存在异质性,随访时间有限,难以确定慢性大麻使用是否是因果关系,仅是与 CVS 的临床关联,还是在本来就容易患上 CVS 的患者中揭示或引发症状。本文将讨论大麻在调节恶心和呕吐中的作用,特别是针对 CVS 和 CHS,以解决这方面的争议。为此,我们收集和分析了关于 CHS 的已发表病例系列和病例报告,以确定符合当前罗马 IV 标准的 CHS 报告病例数。我们还确定了现有诊断框架中的局限性,并提出了诊断 CHS 的修订标准。该领域的未来研究应能提高我们对大麻使用在周期性呕吐中的作用的理解,并帮助我们更好地理解和管理这种疾病。